Last reviewed · How we verify
NCT05815537
Development of Functional Spatial Hearing in Reverberation
EARLY_PHASE1 trial testing Low-Reverberation in Spatial Hearing Development in 116 participants. Completed in 30 June 2025.
28 March 2025
Quick facts
| Lead sponsor | Father Flanagan's Boys' Home |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 116 |
| Start date | 1 January 2024 |
| Primary completion | 28 March 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Low-Reverberation
- High-Reverberation
Conditions studied
- Spatial Hearing Development — all drugs for Spatial Hearing Development →
Sponsor
Father Flanagan's Boys' Home
Who can join
Adults 6 to 30, any sex, with Spatial Hearing Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the clinical trial study (Phase 0) is to map out the developmental trajectory of functional spatial hearing abilities in reverberant environments for children with normal hearing between the ages of 6 and 18 years, and to understand the inter-relationships between the three perceptual abilities: auditory object size formation, spatial acuity, and spatial unmasking during typical development. Children are asked to perform psychoacoustic tasks when the auditory stimuli are processed to present in virtual acoustic environments (1) with no reverberation and (2) with one of the two levels of reverberation that emulate everyday indoor environments. The intervention of this clinical study is in the random assignment of one of the two reverberant environments. Researchers will compare these children with a group of normal-hearing adults to anchor matured performances.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05815537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Father Flanagan's Boys' Home trials
Trials by the same sponsor.
- NCT06794476 — Milieu Teaching-AV (MT-AV Pilot) · NA · withdrawn
- NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
- NCT04558541 — A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production · NA · recruiting
- NCT05486637 — Vocal Emotion Communication With Cochlear Implants · EARLY_PHASE1 · recruiting
- NCT05414903 — Reading Outcomes in Children With Vestibular Loss · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05815537 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Father Flanagan's Boys' Home
- Last refreshed: 27 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05815537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing